Navigation Links
Techne Corporation Announces Acquisition
Date:4/4/2011

MINNEAPOLIS, April 4, 2011 /PRNewswire/ -- Techne Corporation (NASDAQ: TECH) announced today that as of April 1, 2011, its R&D Systems subsidiary has acquired the assets of Boston Biochem, Inc., a leading developer and manufacturer of innovative ubiquitin-related research products.  These products provide biomedical researchers the tools that facilitate and accelerate basic research and drug discovery efforts.  R&D Systems Europe simultaneously acquired the assets of Boston Biochem Limited, a United Kingdom based company that serves as the European markets distributor of the Boston Biochem, Inc. products.  R&D Systems is a leading developer and manufacturer of purified cytokines (proteins), antibodies and assay kits which are sold to biomedical researchers and clinical research laboratories.

Boston Biochem was founded in 1997 and currently offers over 800 ubiquitin-related products.  The Ubiquitin Proteasome Pathway is the principal system for protein degradation and signaling in eukaryotic cells.  Ubiquitination also affects proteasome-independent events such as protein localization, activity and function.  These pathways are central to the regulation of almost all cellullar processes.  Ubiquitin and related pathways are associated with the regulation of numerous disease states including multiple cancers, diabetes, Parkinson's, Alzheimer's, cystic fibrosis, Angelman's syndrome, Liddle syndrome and Wilson's disease.

The acquisitions will enhance and supplement the depth and breadth of R&D Systems' product offering and will augment its ability to serve research scientists, as well as leverage its marketing, sales and distribution capabilities with this important product class.

Boston BioChem, Inc. and Boston BioChem Limited had combined product sales of about $2.5 million in calendar 2010 and, therefore, the acqu
'/>"/>

SOURCE Techne Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
2. Techne Corporation Announces That Dr. Roeland Nusse Has Accepted a Seat on Its Board of Directors
3. Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010
4. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
5. Techne Corporation Declares Dividend
6. TechNet Urges Swift U.S. Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell
7. Techne Corporation Board Member Recognized
8. Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
9. Techne Corporation Announces That John L. Higgins has Accepted a Seat on Technes Board
10. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
11. Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Earlier this year in a June 24 international ... Adult Stem Cell Technology Center, LLC ( ASCTC ) ... unique property of adult tissue stem cells. His ... the Past, Important for the Future,” embodied the essence ... the address at the 4th World Congress on Cell ...
(Date:12/24/2014)... The report provides basic ... definition, classification, application and industry overview. This ... and product cost structure. Production is separated ... also covers upstream raw materials, equipment, downstream ... and proposals. In the end, the export ...
(Date:12/24/2014)... , Dec. 23, 2014 China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that its majority-owned subsidiary, Shandong Taibang Biological Products ... certification from the China Food and Drug Administration ... facility. As previously disclosed in the Company,s public ...
(Date:12/24/2014)... , Dec. 23, 2014  Rock Creek Pharmaceuticals, ... it has filed a Clinical Trial Application (CTA) with ... products Regulatory Agency (MHRA) seeking regulatory approval to initiate ... molecule, Anatabine Citrate. Contingent on the Company ... a Phase I trial to assess the safety, tolerability ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... Although Madison has made a deal with Georgia-based ... deployment will not be an overnight event. Certain areas will ... around Capitol Square expected to be approved by the City ... the city of Madison has taken an active role in ...
... vice president Kevin Conroy is stepping into the shoes of ... and previously held other executive roles at the company, has ... a specific purpose," Puisis said in a statement. "With a ... place, that purpose has been completed." , ,Third Wave is ...
... has tripled Third Wave Technologies ' compensation in ... $15.9 million plus legal fees. Stratagene is proceeding with ... after the judge found that Stratagene willfully infringed on ... Third Wave $5.3 million. , ,Third Wave uses the ...
Cached Biology Technology:Madison wireless deal goes forward with Cellnet 2
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... 20, 2014 C-Labs LLC, a leading provider ... Things (IoT), today announced the appointment of John ... Previously a strategic advisor to the firm, Mr. Traynor ... Traynor is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... BOSTON , Nov. 17, 2014   ... HealthCare and EMC collaborate to develop The Partners ... , The Partners Data Lake will allow ... to improve diagnostics, treatment and the lives of ... support research and clinical activities across the Partners ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... in immune cells may be a reliable marker for ... appearing in the July issue of Molecular and ... and complex psychiatric illness that affects about 1% of ... and the assessment of ambiguous symptoms, which frequently leads ...
... JULY 7, 2008 -- The Soil Science Society of ... Sherrod Brown and his colleagues in the Senate who ... "essential" natural resource, placing soil on par with water ... joined by co-sponsoring Senators Kent Conrad (D-ND), Charles Grassley ...
... The effective treatment of many forms of cancer continues ... fail to respond to standard forms of chemotherapy or ... Centre for Infection Research (HZI) in Braunschweig, the Hannover ... now discovered a chemical mechanism with which a natural ...
Cached Biology News:Senate resolution shines spotlight on the importance of soils 2Argyrin: Natural substance raises hope for new cancer therapies 2
GLP-1 (HYB 147-12)...
... Custom Synthesis Service provides you ... to knockdown any gene. We ... base pairs with terminal dT ... other lengths of your choice. ...
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19...
Biology Products: